YPSN.SW
YPSN.SW
CH0019396990
YPSOMED HLDG
Loading chart...

Company Profile

Ypsomed Holding AG, together with its subsidiaries, develops, manufactures, and sells injection and infusion systems for safe and simple self-medication in Switzerland, Europe, North America, and internationally. The company offers various injection systems, such as pen injectors, auto-injectors, and wearable injectors, as well as other related services. It offers contract manufacturing of infusion sets and reservoirs. The company markets its products to hospitals, doctors, pharmacies and patients via subsidiaries and distributors. Ypsomed Holding AG was founded in 1984 and is headquartered in Burgdorf, Switzerland.

Related stocks

TECN.SW
TECN.SW • Switzerland
TECAN GROUP AG N
235 CHF
3.49B USD 1Y +55.4%
CTEC.L
CTEC.L • United Kingdom
CONVATEC GROUP PLC ORD 10P
220 GBp
5.58B USD 1Y -11.3%
STVN
STVN • Italy
Stevanato Group S.p.A.
19.4 USD
5.3B USD 1Y -21.8%
SKAN.SW
SKAN.SW • Switzerland
SKAN N
70.7 CHF
1.92B USD 1Y +22.5%
OBCK.DE
OBCK.DE • Germany
Ottobock SE & Co. KGaA I
53.2 EUR
3.81B USD
1SXP.DE
1SXP.DE • Germany
SCHOTT Pharma AG & Co. KGaA I
23.5 EUR
3.97B USD 1Y +20%
ALC.SW
ALC.SW • Switzerland
ALCON N
53.14 CHF
30.95B USD 1Y -12.3%
FIE.DE
FIE.DE • Germany
Fielmann Group AG I
37.35 EUR
3.51B USD 1Y -25.6%

Key Metrics & Overview

Detailed metrics & financial data of the company

Company Profile
5 Metrics

🛡️ Risk & Structural Analysis

Multi-Factor Risk Model & Market Data

7/7 Very High
5Y Volatility
31.7% p.a.
Max Drawdown (5Y)
-38.9%
Sharpe Ratio (5Y)
0.51
Beta Factor
0.81
Size Class
Mid Cap
Notes & Warnings
Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).
Exemplary balance sheet strength: Very solid ratio of equity to debt.
Structurally High Volatility: Above-average fluctuations persist across 5 to 10 years (31.7% p.a.).
Historical Stress Test: Maximum peak-to-trough drawdown of -53.2% in the extended horizon.
ende